PATHOGENOMIC RESEARCH IN HUNGARY PRESENT STAGE AND PERSPECTIVES Ideas for cooperation L. Emődy - B. Nagy ERE-NET PathoGenoMics Meeting Bonn, 07.-08. April,

Slides:

Advertisements

Similar presentations

Hungarian GEnomic Research on pathogenic Microbes Hu-GERM.

Advertisements

Lateral Transfer. Donating Genes Mutation often disrupts the function of a gene Gene transfer is a way to give new functions to the recipient cell Thus,

The Microbiome: What’s the immune system got to do with it?

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP 25 October 2013.

Characterizing Uncultured Bacteria Michael Wagner Division of Microbial Ecology University of Vienna.

Antimicrobial Resistance Surveillance Latin America

Goals of PATHOGENOMICS related research Chief Scientist Office Ministry of Health Israel.

Medical Diagnostics NIAID Funding Opportunities Maria Y. Giovanni, Ph.D. Assistant Director for Microbial Genomics and Advanced Technologies National Institute.

Pathogenomics: Focusing studies of bacterial pathogenicity through evolutionary analysis of genomes.

WHO Global Salm-Surv: A Global Salmonella Surveillance Network World Health Organization, Geneva Centers for Disease Control and Prevention, Atlanta Danish.

Food Microbiology 08/11/11.

Gilbert H. John, Ph.D. Department of Microbiology & Molecular Genetics Stillwater, OK Azoreductase Activity in Intestinal Bacteria.

Aynaz Taheri 1 C. Gyles and P. Boerlin. * Transfer of foreign DNA * Mechanisms of transfer of DNA * Mobile genetic elements (MGE) * MGEs in the virulence.

Global Antibiotic Use and the Rise of Resistance BioQUEST Summer Workshop June 12 – 13, 2010 Julie Seiter, Oakland Community College Ethel Stanley, BioQUEST,

Development of new tools to study the cell biology and origins of phenotypic variation in the human pathogen Streptococcus pneumoniae: An overview of recently.

BIO 411 – Medical Microbiology Chapter 9 Commensal and Pathogenic Microbial Flora.

Genetic transfer and recombination

Sequencing capacitiesacademic company based microarray facilitiesacademic company based bioinformaticsacademic proteomic facilitiesacedemic Genome Research.

FORESIGHT STUDY Future Trends and Challenges in Pathogenomics JUDITH SIMON & SVEN POMPE PROGRAMME GROUP MUT.

Multidrug resistant organisms: What are we up against? Hans Jørn Kolmos MD DMSc Professor, consultant Department of Clinical Microbiology Odense University.

CHOICE OF ANTIBIOTICS IN THE VIEW OF DEVELOPING ANTIBIOTIC RESISTANCE Dr. Jolanta Miciulevičienė Vilnius City Clinical Hospital National Public Health.

Hans Wolf-Watz, professor, UCMR, MIMS, Department of Microbiology, Umeå University, Sweden, Antibiotic resistance a new.

Pathogen Biology & Translational Medicine Wellcome Trust Centre for Human Genetics International Scientific Advisory Board Tuesday 15 th February 2011.

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP.

A new antivirulence approach against pathogenic bacteria A new antivirulence approach against pathogenic bacteria May 2005 Sonia Escaich - President &

ERA-NET PathoGenoMics Meeting Bonn 7-8 April, 2005 Research topics of interest in the Area of Genomics of Bacterial and Fungal Pathogens of Humans Prof.

Infections of the GI Tract November 19, 2007 NCDD Meeting Chair: Mitchell B. Cohen, MD Vice Chair: Richard S. Blumberg, MD.

Nosocomial infection Hospital Infection. Hospital acquired infections Nosocomial infections are those that originate or occur in a hospital or hospital-like.

Methicillin-resistant Staphylococcus Aureus - MRSA - Sharon Walker, RN, BPS Ingham County Health Department.

GENOME SEQUENCING AND FUNCTIONAL GENOMICS NATIONAL PROGRAM IN LATVIA AND ERA-NET “PATHOGENOMICS” Viesturs Baumanis, Latvian Council of Science Berlin,

CEITEC BRNO | CZECH REPUBLIC central european institute of technology CEITEC Genomics and proteomics at MU Jiří Fajkus.

U.S. Dept. Agriculture Agricultural Research Service Rob Griesbach Technology Transfer Coordinator

Escherichia coli O157:H7 and Shiga toxin-converting bacteriophage Edward G. Dudley, Ph.D Department of Food Science

National and International Spread of Antimicrobial Resistance: Clones and Genes Professor Alan Johnson, Health Protection Services - HPA.

MICROBES AND MAN Research Programme October 13, 2004 Berlin Soile Juuti Programme manager Finland.

WP3 Strategic analysis of the future perspectives for cooperation and coordination Summary of the expert workshop on the European Research Agenda (WP 3)

Laboratory of Enteric and Sexually Transmitted Diseases Historical Perspective Origin: Began in Established to review the rapidly increasing.

Multivalent pneumococcal vaccines can increase the transmissibility and virulence of non-vaccine strains Eleanor Watkins, Caroline Buckee, Bridget Penman,

P ATHO G ENO M ICS PORTUGAL Partner 9 P ATHO G ENO M ICS PORTUGAL Partner 9.

Host-Parasite Relationship Normal Flora Pathogens Infections Opportunistic pathogens.

Bacterial Virulence Factors Dongwoo Shin Laboratory of Molecular Bacteriology Department of Molecular Cell Biology Sungkyunkwan University School of Medicine.

Small Talk Cell-to-Cell Communication in Bacteria.

Global network analysis of drug tolerance, mode of action and virulence in methicillin-resistant S. aureus Chloe Jones Loyola Marymount University BIOL368:

Division of Bacterial, Parasitic and Allergenic Products Jay E. Slater, MD Director, DBPAP.

Genetic Screenings for Studying Bacterial Pathogenesis Dongwoo Shin, Ph.D. Associate Professor, Department of Molecular Cell Biology, Sungkyunkwan University.

R&D IN HUNGARY National Research and Technological Innovation Fund Independent central government office responsible for R&D Expected new budget: approx.

Ministry of Education, Science and Sport Republic of Slovenia Ministry of Education, Science and Sport Republic of Slovenia Research in Slovenia Dr. Livija.

Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.

1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.

Pathogenomics How this project began: Ann Rose - take advantage of DNA sequence information - genomics Julian Davies - use the information to understand.

Introductory medical bacteriology Chien-Ming Li MD, Ph.D.

Pathogenicity of Bacteria. Campylobacter spp. Salmonella spp. Escherichia coli 76 Million Cases of Food-borne illness every year in the USA 325,000 result.

Commensal and Pathogenic Microbial Flora in Humans

Inhibiting Microbial Growth in vivo CLS 212: Medical Microbiology.

GENOMICS TO COMBAT RESISTANCE AGAINST ANTIBIOTICS IN COMMUNITY-ACQUIRED LRTI IN EUROPE (GRACE) H. Goossens (Coordinator), K. Loens (Manager), M. Ieven.

Introduction to Microbiology & Handwashing

The rate of evolution Where selection pressures are high, the rate of evolution can be rapid.

Epidemiology of Hospital Acquired Infections By Alena Bosconi, Candice Smith, Dusica Goralewski SUNY Delhi Biol , Infection and Disease Dr. Marsha.

MALDI TOF analysis of Streptococcus pneumoniae from Cerebrospinal Fluid for the diagnosis of Acute Bacterial Meningitis Dr. R. Ravikumar, M.D., Professor.

Phage therapy for the treatment for urinary tract infection: Results of in-vitro screenings and in-vivo application using commercially available bacteriophage.

Department of Immunochemistry of Glycoconjugates

NCRIAH, Russian Academy of Agricultural Sciences, Krasnodar

Prof. Ramesh Wigneshweraraj

Principles of Medical Microbiology

A new antivirulence approach against pathogenic bacteria

Antimicrobial Resistance: Plans for Korea and Beyond

Non-antibiotic strategies for sepsis

Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange Sandra Y. Wotzka, Bidong D. Nguyen,

Salmonella Typhimurium Diarrhea Reveals Basic Principles of Enteropathogen Infection and Disease-Promoted DNA Exchange Sandra Y. Wotzka, Bidong D. Nguyen,

Diagnostic tools for intestinal pathogenic E. coli.

Presentation transcript:

PATHOGENOMIC RESEARCH IN HUNGARY PRESENT STAGE AND PERSPECTIVES Ideas for cooperation L. Emődy - B. Nagy ERE-NET PathoGenoMics Meeting Bonn, April, 2005

CENTERS OF PATHOGENOMIC RESEARCH IN HUNGARY

IDEAS FOR FUTURE COOPERATION FIELDS WITH HUNGARIAN PARTNERS Enterobacterial pathogenomics: Human intestinal and extraintestinal E. coli, Salmonella, Yersinia Univ. Med. Sch. Pécs, Dept. Med.Microbiol. Immunol. Contact person: Levente Emődy, Veterinary aspects of E. coli and Salmonella Vet. Med. Res. Inst., Hungarian Acad. Sci. Contact person: Béla Nagy, Genome plasticity of Escherichia coli: genome evolution studies Biol. Res. Ctr. Szeged Contact person: György Pósfai,

IDEAS FOR FUTURE COOPERATION FIELDS WITH HUNGARIAN PARTNERS (ctnd) Gram positive pathogens: pathogenomics and resistance mechanisms Staphylococcus, Streptococcus (including pneumococci), Enterococcus Contact person: Ferenc Rozgonyi, Anaerobes: pathogenomics and resistance mechanisms Bacteroides spp. Clostridium difficile Univ. Med. Sch., Szeged, Dept. Clin. Microbiol. Contact person: Elisabeth Nagy,

IDEAS FOR FUTURE COOPERATION FIELDS WITH HUNGARIAN PARTNERS (ctnd) Helicobacter pylori: interactions governed by genetic makeup of the host and parasite Univ. Med. Sch. Szeged, Dept. Med. Microbiol. Immunobiol. Contact person: Yvette Mándi, Mycobacteria: molecular mechanisms of reactivation Univ. Med. Sch. Szeged, Dept. Med. Microbiol. Immunobiol. Contact person: András Miczák, Chlamydia pneumoniae: genetic factors involved in the development of atherosclerosis National Center for Epidemiology Contact person: Éva Gönczöl,

IDEAS FOR FUTURE COOPERATION FIELDS WITH HUNGARIAN PARTNERS (ctnd) Fungal pathogens: genetic background of virulence, and development of new antifungal agents Univ. Szeged, Fac. Sci. Dept.Microbiol. Contact person: Csaba Vágvölgyi, Univ. Debrecen, Fac. Sci. Dept. Microbiol. Contact person: Pócsi István, Univ. Med. Sch. Debrecen, Dept. Med. Chem Contact person: Viktor Dombrádi, Univ. Pécs, Fac. Sci. Dept. Gen. Envirol. Mirobiol. Contact person: Miklós Pesti,

Hungarian Scientific Research Fund (OTKA) grants involving pathogenomic topics: Attenuation of Escherichia coli by global regulatory mutations. (Emődy L.) Investigations on the pathogenicity of enteroinvasive bacteria. (Pál T.) Investigations with a regulatory mutant vaccine candidate Salmonella enterica strain eliciting cross-immunity in mice. (Nagy G.) The role of horizontal gene transfer in the evolution of enterotoxic and cytotoxic Escherichia coli bacteria. (Nagy B.) Occurence in Hungary, and molecular biological characterization of cytolethal distending toxin (CDT), a new cytotoxin.(Tóth I.) Investigations on genome-evolution and plasticity by genome reduction. (Pósfai G.) Investigations on the mechanism of human enterobacterial infections. (Győrffy Z.) Multi-drug resistence types in Pseudomonas aeruginosa. (Szabó D.)

Hungarian Scientific Research Fund (OTKA) grants involving pathogenomic topics (ctnd): In vitro and in vivo pathogenomic studies on methicillin resistant and methicillin sensitive Staphylococcus aureus strains. (Rozgonyi F.) Molecular biological studies on virulence factors of bacteria causing anaerobic infections. (Nagy E.) Cytokine gene polymorphism in diseases of microbial and complex origin. (Mándi Y.) Reactivation of mycobacteria. (Miczák. A.) Genetic background of the relationship between atherosclerosis and Chlamydia pneumoniae. (Gönczöl É.)

Hungarian Scientific Research Fund (OTKA) grants involving pathogenomic topics (ctnd): Studies on fungal metabolism in order to develop new type antimycotic agents. (Pócsi I.) Regulation of autolytic processes in Aspergillus nidulans. (Pócsi I.)

Hungarian partners in international grants involving pathogenomic topics: EU FP6. Network of Excellence. European Virtual Institute for Functional Genomics of Bacterial Pathogens (EuroPathoGenomics). Coordinator: J. Hacker, University of Würzburg, Hungarian coordinator: B. Nagy. Partner 23: B. Nagy, Veterinary Medical Research Institute, Hungarian Academy of Sciences, Budapest Partner 24: L. Emődy, University Medical School, Pécs EU FP6. Salmonella free broiler by live vaccine induced innate resistance to colonization and invasion and novel methods to eliminate vaccine and field strains (SUPASALVAC) Coordoinátor: P.A.Barrow CR5. partner, (WP1 leader): B. Nagy, Veterinary medical Research Institute, Hungarian Academy of Sciences, Budapest

Hungarian partners in international grants involving pathogenomic topics (cntd): Bilateral German-Hungarian Science and Technology Grant. (J. Hacker- L. Emődy): Studies on urinary Escherichia coli infections in order to develop new diagnostic, therapeutic and preventive measures. Bilateral German-Hungarian Science and Technology Grant. (J. Hacker- B. Nagy): Studies on virulence genes of enterotoxigenic and verotoxigenic Escherichia coli: new opportunities for prevention of disease and for increased food safety. Bilateral Austrian-Hungarian Science and Technology Grant. (F. Rozgonyi): In vitro and in vivo studies on the pathomechanism and pathogenesis of community acquired and nosocomial S. aureus infections. Bilateral British-Hungarian Science and Technology Grant. (F. Rozgonyi): Antibiotic sensitivity and molecular typing of Streptococcus pneumoniae strains isolated in Hungary.